Editorial team
ioQuanta Research Desk
-
Evidence date ·Enzymes can shape polymers, but what happens to the finished material?
Review or Meta-AnalysisEnzymes can prepare building blocks, form polymer chains and alter surfaces. A 2021 review explains why breakdown still depends on the material and its surroundings.
-
Evidence date ·Why treatment history changes what immune cells may mean in glioblastoma
Review or Meta-AnalysisTracked over timeA seven-study review linked higher CD8 immune-cell counts with worse survival in some treated glioblastoma patients, showing why sample timing matters.
-
Evidence date ·Dual immune blockade changed T cells and suppressive cells in mouse glioblastoma tumors
Clinical TrialTracked over timeIn mice with glioblastoma, paired checkpoint blockade extended survival, raised the share of CD8 T cells in tumors and reduced one suppressive-cell subtype.
-
Evidence date ·When and how did brain inflammation appear after cancer immunotherapy?
Review or Meta-AnalysisIn a review of 54 reported cases, brain inflammation began after a median of three cancer immunotherapy cycles, with very early and late cases also described.
-
Evidence date ·Where could biomass-derived products fit inside a car?
Review or Meta-AnalysisA 2021 review explores how biomass-derived products could fuel cars, help build them or store electricity, while noting that widespread commercial use remains limited.
-
Evidence date ·Do brain, liver and bone metastases tell different stories during lung cancer immune treatment?
Review or Meta-AnalysisA 25-study review linked brain and liver spread to earlier progression and poorer survival, while bone spread showed a less consistent pattern.
-
Evidence date ·What new ways to target Akt, a protein linked to cell growth, appeared in patents?
Review or Meta-AnalysisA 2021 patent review traces new Akt inhibitor designs and emerging immunotherapy combinations, while showing how patent proposals differ from treatment evidence.
-
Evidence date ·What helps T cells keep responding after PD-1 blockade?
Review or Meta-AnalysisA 2021 review connects TCF-1 to T-cell memory and sustained immune responses after PD-1 blockade, explaining its possible use as a marker or treatment target.
-
Evidence date ·Why a change in blood tumor DNA may matter more than the starting level
Review or Meta-AnalysisTracked over timeA 2026 review found that early drops in tumor DNA during immunotherapy for advanced lung cancer tracked with longer survival, but scans still guide care.
-
Evidence date ·What can changing blood clues reveal during lung cancer immunotherapy?
Review or Meta-AnalysisTracked over timeA 2023 review links falling tumor DNA in blood with better outcomes during immunotherapy for lung cancer and explores what rare tumor cells and tiny vesicles may add.